Recently cleared by the FDA, the iQ3 point-of-care ultrasound system reportedly offers new advances in 3D imaging capabilities.
Offering a combination of enhanced image processing, artificial intelligence (AI) tools and improved 3D imaging, the Butterfly Network has unveiled the iQ3TM handheld ultrasound.
In addition to a “no focus” rubber lens that facilitates improved observation of small anatomical structures, the iQ3 point-of-care device also features 3D imaging advances with iQ Slice and iQ Fan.
Butterfly Network said the iQ Slice technology features automated steering of the beam for optimal organ scanning and can capture 46 ultrasound slices simultaneously across a wide angle. With real-time virtual fanning, the iQ Fan provides clinicians with smoother visualization of A-lines and other lung conditions, according to Butterfly Network.
The company added that these 3D imaging advances with the iQ3 device are combined with existing AI tools, six imaging modes and over 20 anatomical presets in Butterfly Network ultrasound devices.
“The introduction of Butterfly iQ3 includes a focus on higher precision capabilities for cardiovascular point-of-care ultrasound applications to inform complex decisions,” noted Partho Sengupta, M.D., the chief of cardiology at Rutgers Robert Wood Johnson Medical School. “In my early experience, I found that the enhancements in visualization technology and artificial intelligence, as well as image quality will greatly assist health care professionals in our efforts to continually improve outcomes for our patients.”
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Month, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.